Supernus Pharmaceuticals, Inc. (SUPN)

50.74 -0.37 (-0.72%) USD  |  NASDAQ  |  Jan 12, 10:41
More

Supernus Pharmaceuticals EBITDA Margin (TTM)

EBITDA Margin (TTM) Chart

View EBITDA Margin (TTM) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin (TTM) Range, Past 5 Years

View EBITDA Margin (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (TTM) Benchmarks

View EBITDA Margin (TTM) Benchmarks
Start Trial
Amphastar Pharmaceuticals, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Catalyst Pharmaceuticals, Inc. Upgrade
Assembly Biosciences, Inc. Upgrade
Viking Therapeutics, Inc. --